AJP - Heart AJP citation statistics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol (December 22, 2005). doi:10.1152/ajpheart.00772.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/5/H2035    most recent
00772.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gonscherowski, V.
Right arrow Articles by Zahler, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonscherowski, V.
Right arrow Articles by Zahler, S.
Submitted on July 30, 2004
Accepted on December 14, 2005

Calpains - a physiological regulator of the endothelial barrier?

Vera Gonscherowski1, Bernhard F Becker1*, Luis Moroder2, Elena Motrescu3, Shirley Gil-Parrado4, Torsten Gloe1, Matthias Keller1, and Stefan Zahler1

1 Physiology, University of Munich, Munich, Germany
2 Biochemistry, Max-Plank-Institute, Martinsried, Germany
3 Medical Elecrtonics, Technical University, Munich, Germany
4 Clinical Chemistry and Clinical Biochemistry, University of Munich, Munich, Germany

* To whom correspondence should be addressed. E-mail: B.F.Becker{at}lrz.uni-muenchen.de.

The intracellular protease calpain, abundant in endothelial cells (EC), is assumed to be inactive under physiological conditions but may account for Ca++-linked pathophysiological events. However, non-stimulated EC contained autolysed, activated calpain. Adding 12-48µM calpain inhibitor I (CI) or 0.5-1µM of the novel, membrane permeable conjugate of calpastatin peptide-penetratin (CPP) caused rapid rounding and retraction of cultured EC (phase contrast, capacitance), and translocation of Syk, Rac and Rho to the membrane, signifying activation upon inhibition of calpain. Isolated hearts (guinea pig) perfused with 12 µM CI or 0.5 µM CPP developed coronary leak. We conclude that calpain is constitutively active in EC and regulates vascular permeability by governing cell-cell attachment.




This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
T. Miyazaki, K. Honda, and H. Ohata
m-Calpain antagonizes RhoA overactivation and endothelial barrier dysfunction under disturbed shear conditions
Cardiovasc Res, October 7, 2009; (2009) cvp311v2.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. Scalia, Y. Gong, B. Berzins, L. J. Zhao, and K. Sharma
Hyperglycemia Is a Major Determinant of Albumin Permeability in Diabetic Microcirculation: The Role of {micro}-Calpain
Diabetes, July 1, 2007; 56(7): 1842 - 1849.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.